Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03854344 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
A Phase 4 study of Pain, Postoperative and Burns, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT03854344: Recruiting Phase 4 study of Pain, Postoperative and Burns, sponsored by University of Kansas Medical Center.
NCT03854344 is a Phase 4 study of Pain, Postoperative and Burns that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 75 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03854344, a Phase 4 study of Pain, Postoperative and Burns, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Donor site pain study comparing post-operative donor site pain and opioid consumption after use of Lidocaine, Liposomal Bupivicaine or regional nerve block for split thickness skin graft harvesting in patients with less than 20% TBSA burn wounds and less than %5 Deep partial or full thickness burn wounds.
Primary Outcome
Pain score involving skin graft donor sites are measured using a Visual Analog Scale, which is a horizontal line numbered 0-10, with 10 being the worst pain imaginable and 0 indicating no pain and compare pain scores between donor sites treated with Exparel Vs Lidocaine
Conditions Studied
Interventions
- DRUG Liposomal bupivacaine
- DRUG Bupivacaine Hydrochloride
- DRUG Lidocaine Hydrochloride
Study Locations (1)
Kansas
- The University of Kansas Health System - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 4 |
What NCT03854344 shows while recruiting
NCT03854344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (72% lower).
The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 3 interventions - of which Liposomal bupivacaine is the first listed.
NCT03854344 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT03854344 about?
NCT03854344 is a clinical study titled "Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain". Donor site pain study comparing post-operative donor site pain and opioid consumption after use of Lidocaine, Liposomal Bupivicaine or regional nerve block for split thickness skin graft harvesting in patients with less than 20% TBSA burn wounds and less than %5 Deep partial or full thickness burn w...
What is the current status of trial NCT03854344?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2019-03-18. Estimated completion is 2025-12-31.
What conditions does trial NCT03854344 study?
This clinical trial studies the following conditions: Pain, Postoperative, Burns.
What interventions are being tested in trial NCT03854344?
The interventions under investigation include: Liposomal bupivacaine (DRUG), Bupivacaine Hydrochloride (DRUG), Lidocaine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT03854344?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03854344 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03854344's enrollment target sits among peer trials
75 66th of 113 higher than 46 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI